On Nov. 21, the U.S. Food and Drug Administration (FDA) approved Juluca, the first treatment regimen containing two drugs to treat certain adults with HIV-1 instead of three or more drugs included in standard HIV treatment.
Read more via Fda.gov.
FDA approves first two-drug regimen for HIV
Share
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.
NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.
